Cutera Announces Leadership Change and Preliminary Financial Results for Full Year 2018
CEO James Reinstein Resigns as President, Chief Executive Officer and Board member COO Jason Richey to Serve as Interim CEO […]
Attis Industries Launches Video Series Demonstrating the Benefit of PGx Testing for Employers
MILTON, GA, Jan. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), […]
Cellectar Provides Update on Phase 1 Trial of CLR 131 in Relapsed/Refractory Multiple Myeloma
Median overall survival of 22.0 months observed in Cohorts 1-4 FLORHAM PARK, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) — Cellectar […]
II-VI Incorporated to Present at J.P. Morgan 17th Annual Tech Forum at the 2019 International CES
PITTSBURGH, Jan. 07, 2019 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq: IIVI), a global leader in engineered materials and optoelectronic components, […]
Winners of the 2019 AutoWeb Buyer’s Choice Awards Announced
IRVINE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) — AutoWeb, Inc. (Nasdaq: AUTO), a robust digital marketing platform providing advertising solutions […]
Cowen Announces Additions to Capital Markets and the Appointment of Scott Hague as Head of Private Capital Solutions
NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Scott Hague […]
Bellerophon Announces Top-line Results from Cohort 1 of the INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Statistically Significant Improvements in Multiple Clinically Meaningful Activity Parameters Demonstrated WARREN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. […]
Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners
Novos to provide fully integrated commercial function for Evoke and non-dilutive financing for the commercialization of Gimoti, extending cash runway […]
Aptevo Therapeutics Highlights Key 2019 Priorities
ADAPTIR™ Bispecific Antibody Candidates Poised to Progress in Clinical Development APVO436 Advancing in Phase 1 Clinical Trial for Acute Myeloid […]
Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
AUSTIN, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage drug development company, today announced two […]
